300049.SZ
Inner Mongolia Furui Medical Science Co., Ltd.
ShenzhenCNYEQUITY
Healthcare
DELAYED
Last price
37.94
▼ 3.73 (8.95%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
41.29
Prev close
41.67
Day high
41.50
Day low
37.49
Volume
12.11M
Market cap
$10.02B
P/E (TTM)
64.32
52W range
36.50 – 90.68
Day trading desk
Gap from prior close
-0.91%
Prior close 41.67
VWAP
38.28
-0.90% from price
Relative volume
2.32×
Unusually busy
Session range
10.64%
37.49 – 41.48
Position in range
11%
Near session low
ATR (14D)
3.03
7.98% of price
Prior day high
42.89
PDH
Prior day low
41.22
PDL
Bid / ask spread
—
Quote not published
Session volume
21.30M
Avg 9.20M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-15.33%
-14.2%
1M
-10.13%
-13.5%
3M
-23.72%
-26.1%
6M
-42.67%
-54.6%
YTD
-46.10%
-58.1%
1Y
-21.20%
-41.4%
3Y
+72.89%
-2.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 300049.SZ open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
63.32M
Total on file
Fundamentals
Market cap$10.02B
Enterprise value$10.87B
Revenue (TTM)$1.63B
Gross profit$1.21B
EBITDA$482.37M
Net income$157.25M
EPS (TTM)$0.59
Free cash flow$328.72M
Total cash$749.08M
Total debt$79.96M
Book value / share$7.48
Shares outstanding263.99M
Float203.15M
Short % of float—
Dividend yield0.36%
Beta (5Y)-0.28
Valuation & profitability ratios
Trailing P/E64.32
Forward P/E27.90
PEG ratio—
Price / sales—
Price / book5.07
EV / revenue6.69
EV / EBITDA22.54
Gross margin74.52%
Operating margin19.46%
Profit margin9.68%
Return on equity11.52%
Return on assets7.73%
Debt / equity3.22
Current ratio3.44
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.60B | $1.35B | $1.15B | $1.01B | +18.3% |
| Operating revenue | $1.60B | $1.35B | $1.15B | $1.01B | +18.3% |
| Cost of revenue | $399.36M | $349.04M | $291.39M | $267.67M | +14.4% |
| Gross profit | $1.20B | $999.98M | $862.34M | $741.09M | +19.6% |
| Research & development | $111.20M | $99.49M | $82.47M | $70.82M | +11.8% |
| Selling, general & admin | $171.86M | $176.27M | $167.03M | $179.62M | -2.5% |
| Total operating expense | $796.63M | $691.12M | $620.09M | $555.81M | +15.3% |
| Operating income | $399.40M | $308.85M | $242.25M | $185.28M | +29.3% |
| Net interest income | $15.74M | $13.10M | $8.43M | $3.79M | +20.1% |
| Pre-tax income | $350.56M | $270.55M | $235.40M | $191.63M | +29.6% |
| Tax provision | $92.14M | $74.67M | $58.29M | $46.22M | +23.4% |
| Net income | $154.09M | $113.29M | $101.56M | $97.89M | +36.0% |
| Net income to common | $154.09M | $113.29M | $101.56M | $97.89M | +36.0% |
| Basic EPS | 0.58 | 0.43 | 0.39 | 0.37 | +34.9% |
| Diluted EPS | 0.58 | 0.43 | 0.39 | 0.37 | +34.9% |
| EBIT | $353.79M | $273.32M | $236.30M | $193.21M | +29.4% |
| EBITDA | $455.21M | $364.44M | $317.19M | $265.60M | +24.9% |
| Basic shares | 265.67M | 263.45M | 263.05M | 263.07M | +0.8% |
| Diluted shares | 265.67M | 263.45M | 263.05M | 263.07M | +0.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $649.74M | $566.83M | $509.59M | $479.21M | — | +14.6% |
| Cash & short-term investments | $733.36M | $724.33M | $603.70M | $615.41M | — | +1.2% |
| Accounts receivable | $445.27M | $525.63M | $434.41M | $425.25M | — | -15.3% |
| Inventory | $148.97M | $140.84M | $100.37M | $97.40M | — | +5.8% |
| Total current assets | $1.54B | $1.52B | $1.25B | $1.23B | — | +1.4% |
| Property, plant & equipment | $579.59M | $492.18M | $403.24M | $385.87M | — | +17.8% |
| Goodwill & intangibles | $762.73M | $763.24M | $577.90M | $553.85M | — | -0.1% |
| Total assets | $3.44B | $3.06B | $2.65B | $2.52B | — | +12.4% |
| Total current liabilities | $482.25M | $369.55M | $298.37M | $236.81M | — | +30.5% |
| Current debt | — | — | — | $1.16M | $40.00M | — |
| Total debt | $175.98M | $76.42M | $59.34M | $55.68M | — | +130.3% |
| Total liabilities | $967.33M | $930.99M | $800.09M | $697.25M | — | +3.9% |
| Retained earnings | $915.91M | $768.72M | $663.38M | $664.56M | — | +19.1% |
| Shareholder equity | $1.98B | $1.75B | $1.55B | $1.55B | — | +13.2% |
| Working capital | $1.06B | $1.15B | $956.47M | $993.63M | — | -8.0% |
| Net tangible assets | $1.22B | $984.44M | $969.42M | $991.56M | — | +23.5% |
| Shares issued | 264.98M | 266.36M | 263.05M | 263.05M | — | -0.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $258.42M | $195.88M | $177.11M | $145.41M | +31.9% |
| Depreciation & amortisation | $101.43M | $91.12M | $80.90M | $72.39M | +11.3% |
| Change in working capital | -$69.21M | -$135.76M | $36.73M | -$38.17M | +49.0% |
| Operating cash flow | $351.53M | $221.41M | $304.89M | $189.46M | +58.8% |
| Capital expenditure | -$189.01M | -$218.97M | -$189.23M | -$90.78M | +13.7% |
| Investing cash flow | -$213.03M | -$306.38M | -$150.43M | -$68.45M | +30.5% |
| Dividends paid | -$2.29M | -$2.20M | -$53.42M | -$71.41M | -3.9% |
| Financing cash flow | -$70.26M | $138.52M | -$137.14M | -$126.54M | -150.7% |
| Free cash flow | $162.51M | $2.44M | $115.66M | $98.69M | +6,555.1% |
| End cash position | $640.28M | $559.79M | $509.59M | $479.21M | +14.4% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $360.14M | $494.34M | $383.01M | $330.40M | $369.15M | -27.1% |
| Operating revenue | $360.14M | $494.34M | $383.01M | $330.40M | $369.15M | -27.1% |
| Cost of revenue | $90.42M | $126.97M | $99.71M | $76.77M | $118.80M | -28.8% |
| Gross profit | $269.72M | $367.38M | $283.31M | $253.63M | $250.35M | -26.6% |
| Research & development | $31.52M | $30.02M | $27.78M | $22.18M | $26.65M | +5.0% |
| Selling, general & admin | $162.71M | -$309.52M | -$80.44M | $159.96M | -$287.38M | +152.6% |
| Total operating expense | $195.88M | $227.62M | $206.51M | $184.00M | $148.96M | -13.9% |
| Operating income | $73.84M | $139.76M | $76.80M | $69.63M | $101.39M | -47.2% |
| Net interest income | $11.02M | $34.54M | $14.05M | -$5.65M | $8.26M | -68.1% |
| Pre-tax income | $73.08M | $126.75M | $54.29M | $60.12M | $59.67M | -42.3% |
| Tax provision | $20.96M | $30.32M | $18.01M | $18.44M | $22.94M | -30.9% |
| Net income | $31.79M | $42.20M | $23.30M | $28.64M | $11.28M | -24.7% |
| Net income to common | $31.79M | $42.20M | $23.30M | $28.64M | $11.28M | -24.7% |
| Basic EPS | 0.12 | — | — | 0.11 | — | — |
| Diluted EPS | 0.12 | — | — | 0.11 | — | — |
| EBIT | $73.99M | $127.72M | $55.10M | $60.77M | $60.57M | -42.1% |
| EBITDA | $73.99M | $127.72M | $55.10M | $60.77M | $60.57M | -42.1% |
| Basic shares | 264.95M | — | — | 260.33M | — | — |
| Diluted shares | 264.95M | — | — | 260.33M | — | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $669.04M | $649.74M | $595.24M | $596.32M | $566.83M | +3.0% |
| Cash & short-term investments | $749.08M | $733.36M | $715.74M | $726.22M | $724.33M | +2.1% |
| Accounts receivable | $389.33M | $445.27M | $559.13M | $510.35M | $525.63M | -12.6% |
| Inventory | $150.48M | $148.97M | $153.42M | $140.67M | $140.84M | +1.0% |
| Total current assets | $1.52B | $1.54B | $1.56B | $1.52B | $1.52B | -1.7% |
| Property, plant & equipment | $578.93M | $579.59M | $515.17M | $498.23M | $492.18M | -0.1% |
| Goodwill & intangibles | $761.44M | $762.73M | $791.54M | $772.19M | $763.24M | -0.2% |
| Total assets | $3.42B | $3.44B | $3.16B | $3.08B | $3.06B | -0.5% |
| Total current liabilities | $441.56M | $482.25M | $372.56M | $333.19M | $369.55M | -8.4% |
| Long-term debt | $10.00M | — | — | — | — | — |
| Total debt | $182.72M | $175.98M | $78.27M | $72.71M | $76.42M | +3.8% |
| Total liabilities | $940.06M | $967.33M | $915.80M | $892.56M | $930.99M | -2.8% |
| Retained earnings | $947.70M | $915.91M | $820.65M | $797.35M | $768.72M | +3.5% |
| Shareholder equity | $1.98B | $1.98B | $1.82B | $1.78B | $1.75B | +0.2% |
| Working capital | $1.08B | $1.06B | $1.19B | $1.19B | $1.15B | +1.4% |
| Net tangible assets | $1.22B | $1.22B | $1.03B | $1.01B | $984.44M | +0.4% |
| Shares issued | 264.98M | 264.98M | 266.36M | 266.36M | 266.36M | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Capital expenditure | -$48.08M | -$48.45M | -$48.63M | -$54.61M | -$72.87M | +0.7% |
| Investing cash flow | -$62.96M | -$49.19M | -$56.05M | -$41.41M | -$226.78M | -28.0% |
| Dividends paid | -$534.80K | $19.98M | -$609.07K | -$514.18K | $38.79M | -102.7% |
| Financing cash flow | $1.80M | -$12.76M | -$24.39M | -$6.90M | $137.11M | +114.1% |
| Free cash flow | $43.60M | $90.34M | $10.47M | $20.71M | $27.13M | -51.7% |
| End cash position | $653.08M | $640.28M | $584.93M | $589.24M | $559.79M | +2.0% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | 1.06 | 1 | $2.04B | +28.2% |
| Next year | 1.36 | 1 | $2.42B | +18.6% |
Analyst targets & ownership
Mean target$70.00
High target$70.00
Low target$70.00
Implied upside84.50%
Analyst count1
ConsensusNONE
Strong buy / Buy0 / 2
Hold0
Sell / Strong sell0 / 0
Held by insiders23.90%
Held by institutions12.46%
Institutions holding72
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
43.32
-12.41% from price
SMA 20
44.15
-14.04% from price
SMA 50
42.78
-11.28% from price
SMA 100
47.71
-20.47% from price
SMA 200
57.81
-34.36% from price
EMA 12
42.71
-11.17% from price
EMA 26
43.36
-12.50% from price
EMA 50
44.30
-14.35% from price
RSI (14)
37.7
Neutral
MACD (12,26,9)
-0.65
Hist -0.66
ATR (14)
3.03
7.98% of price
Realised vol 30D
74.0%
Annualised
Bollinger upper
48.47
20, 2σ
Bollinger lower
39.82
20, 2σ
50 / 200 cross
Death
42.78 vs 57.81
Trend bias
Below 200
-34.36%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.17
Less volatile than market
Correlation to SPY
-0.03
Largely independent
Realised vol 30D
74.0%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-57.7%
Peak to trough
Max drawdown 5Y
-57.7%
Peak to trough
ATR 14
3.03
7.98% of price
Beta (reported)
-0.28
5Y monthly, from filing
Dividends & splits
Forward rate$0.15 / yr
Forward yield0.36%
5-year avg yield—
Payout ratio0.00%
Ex-dividend dateJul 6, 2026
Next pay date—
Last split20:10
Split dateJul 6, 2015
Headlines
US dairy industry backs Trump in Canada tariffs row
Just Food · 4m ago
Peako to launch UAV magnetic surveys across five Saudi projects
Mining Technology · 6m ago
Canada's Carney to Announce New Investments to Strengthen Trade Routes After US Talks Collapse
MT Newswires · 9m ago
Leidos Wins $301 Million Cyber Defense Contract
MT Newswires · 10m ago
Davidson Kempner Capital Management LP : Form 8.3 - easyJet plc
GlobeNewswire · 11m ago
Billionaire Stanley Druckenmiller Bought Amazon and Alphabet in Q2. But His Single Biggest Holding Is Neither of Them -- and It's Not Nvidia Either.
Motley Fool · 11m ago
United Vein & Vascular Centers Expands Tampa Bay Network With New South Tampa Vein Clinic
PR Newswire · 12m ago
Brake problems in GM EVs draw greater federal scrutiny
TechCrunch · 12m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.